Response to meta-chlorophenylpiperazine in panic disorder patients and healthy subjects: Influence of reduction in intravenous dosage

Psychiatry Research

Volumn 54, Issue 2, 1994, Pages 115-133

  Germine, Mark ^a   Goddard, Andrew W ^a   Sholomskas, Diane E ^a   Woods, Scott W ^a   Charney, Dennis S ^a   Heninger, George R ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Anxiety; prolactin; serotonin; sex differences

Indexed keywords

(3 CHLOROPHENYL)PIPERAZINE; PLACEBO; PROLACTIN; SEROTONIN;

ADULT; ANXIETY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN EXPERIMENT; HYPERSENSITIVITY; INTRAVENOUS DRUG ADMINISTRATION; MALE; NERVOUSNESS; PANIC; PRIORITY JOURNAL; STRESS;

ADULT; ANXIETY; COMPARATIVE STUDY; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HEART RATE; HUMAN; INJECTIONS, INTRAVENOUS; MALE; PANIC DISORDER; PIPERAZINES; PLACEBOS; PROLACTIN; PSYCHIATRIC STATUS RATING SCALES; PSYCHOMETRICS; SEROTONIN; SEROTONIN AGONISTS; SEX FACTORS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0028670086     PISSN: 01651781     EISSN: None     Source Type: Journal    
DOI: 10.1016/0165-1781(94)90001-9     Document Type: Article

References (34)

1. Soma-significance: A new notion of the relationship between the physical and the mental
2. Neuroendocrine responses to m-chloropiperizine and L-tryptophan in bulimia
3. 1-m-Chlorophenylpiperazine, central serotonin agonist, is a metabolite of trazodone
4. Abnormal regulation of noradrenergic function in panic disorders: Effects of clonidine in healthy subjects and patients with agoraphobia and panic disorder
5. 2-adrenergic and opiate receptor blockade: Synergistic effects on anxiety in healthy subjects
6. Neurobiological mechanisms of panic anxiety: Biochemical and behavioral correlates of yohimbine-induced panic attacks
7. Serotonin function in anxiety: II. Effects of the serotonin agonist MCPP in panic disorder and healthy subjects
8. Noradrenergic function in panic disorder
9. A cognitive approach to panic
10. Serotonergic studies in patients with affective and personality disorders: Correlates with suicidal and impulsive aggressive behavior
11. 1C receptors
12. Does metergoline selectively attenuate 5-HT mediated prolactin release?
13. Treatment implications of baseline anger and of anger response to MCPP in generalized anxiety disorder (GAD)
14. Anger and anxiety responses to m-chlorophenylpiperazine in generalized anxiety disorder
15. Effects of the serotonin reuptake inhibitor fluvoxamine on yohimbine-induced anxiety in panic disorder
16. Neuroendocrine evidence for a serotonin receptor supersensitivity in panic disorder
17. Effects of m-chlorophenylpiperazine in normal subjects: A dose-response study
18. Pituitary hormone responses to meta-chlorophenylpiperazine in panic disorder and healthy control subjects
19. Serotonin receptor sensitivity in major depression
20. Behavioral indications for serotonin receptor hypersensitivity in panic disorder
21. 1C receptor antagonists
22. Anxiogenic effects of m-CPP in patients with panic disorder: Comparison to caffeine's anxiogenic effects
23. Comparative anxiogenic, neuroendocrine, and other physiological effects of m-chlorophenylpiperizine given intravenously or orally to healthy volunteers
24. Hypertonic saline infusion induces panic in patients with panic disorder
25. Serotonin function and depression: Neuroendocrine and mood responses to intravenous L-tryptophan in depressed patients and healthy comparison subjects
26. Pharmacological evidence of supersensitivity of central serotonergic receptors involved in the control of prolactin secretion
27. Effects of ritanserin on the behavioral, neuroendocrine and cardiovascular responses to m-chlorophenylpiperazine in healthy human subjects
28. Fenfluramine provocation of anxiety in patients with panic disorder
29. Caffeine provocation of panic: A focus on biological mechanisms
30. Situational panic attacks: Behavioral, physiologic, and biochemical characterization